MORI, MATTIA
 Distribuzione geografica
Continente #
NA - Nord America 8.589
EU - Europa 6.449
AS - Asia 3.936
SA - Sud America 1.211
AF - Africa 129
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
Totale 20.333
Nazione #
US - Stati Uniti d'America 8.491
RU - Federazione Russa 1.644
SG - Singapore 1.382
GB - Regno Unito 1.151
CN - Cina 1.124
BR - Brasile 1.021
IE - Irlanda 1.010
IT - Italia 900
HK - Hong Kong 434
VN - Vietnam 423
SE - Svezia 341
FR - Francia 333
UA - Ucraina 330
DE - Germania 314
KR - Corea 182
FI - Finlandia 150
AR - Argentina 96
IN - India 95
ES - Italia 50
TR - Turchia 47
CA - Canada 44
BD - Bangladesh 43
ZA - Sudafrica 41
CZ - Repubblica Ceca 39
PL - Polonia 32
AT - Austria 31
MX - Messico 31
NL - Olanda 31
EC - Ecuador 30
ID - Indonesia 30
JP - Giappone 28
CI - Costa d'Avorio 25
IQ - Iraq 21
SA - Arabia Saudita 21
PK - Pakistan 20
BE - Belgio 19
CO - Colombia 18
EG - Egitto 16
BG - Bulgaria 14
MA - Marocco 14
VE - Venezuela 13
IR - Iran 12
KE - Kenya 11
AE - Emirati Arabi Uniti 10
AU - Australia 8
CL - Cile 8
GR - Grecia 8
JO - Giordania 8
PY - Paraguay 8
TN - Tunisia 8
UY - Uruguay 8
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
EU - Europa 7
PE - Perù 7
PT - Portogallo 7
CH - Svizzera 6
IL - Israele 6
UZ - Uzbekistan 6
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
KZ - Kazakistan 4
LB - Libano 4
LV - Lettonia 4
PA - Panama 4
BY - Bielorussia 3
HN - Honduras 3
KG - Kirghizistan 3
LT - Lituania 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
RO - Romania 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
CY - Cipro 2
DK - Danimarca 2
HU - Ungheria 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MY - Malesia 2
OM - Oman 2
SI - Slovenia 2
SN - Senegal 2
TM - Turkmenistan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GI - Gibilterra 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
Totale 20.318
Città #
Dallas 1.601
Southend 1.012
Dublin 1.005
Fairfield 940
Singapore 683
Ashburn 672
Woodbridge 476
Moscow 456
Hong Kong 429
Seattle 415
Beijing 382
Chandler 353
Wilmington 350
Houston 340
Cambridge 328
Siena 309
Santa Clara 254
Jacksonville 221
Ann Arbor 207
Menlo Park 201
Princeton 200
Hefei 187
Seoul 182
Ho Chi Minh City 127
Los Angeles 116
New York 111
San Mateo 97
Munich 91
São Paulo 83
Milan 81
Hanoi 79
Rome 70
San Diego 67
Nanjing 65
Helsinki 63
Dong Ket 62
Boardman 61
Redwood City 60
Buffalo 57
The Dalles 55
Bengaluru 42
Redondo Beach 42
Lappeenranta 40
Fremont 39
Florence 37
London 36
Shanghai 32
Rio de Janeiro 30
Council Bluffs 29
Brno 28
Chicago 28
Nuremberg 27
Phoenix 26
Abidjan 25
Columbus 24
Izmir 24
Nanchang 23
Tokyo 22
Düsseldorf 21
Salamanca 21
Shenyang 20
Brussels 19
San Francisco 19
Belo Horizonte 18
Brasília 18
Jinan 18
Johannesburg 18
Norwalk 18
Curitiba 15
Dearborn 15
Haiphong 15
Montreal 15
Boston 14
Guangzhou 14
Turku 14
Warsaw 14
Atlanta 13
Brooklyn 13
Málaga 13
Salvador 13
Sofia 13
Toronto 13
Baghdad 12
Buenos Aires 12
Chennai 12
Denver 12
St Petersburg 12
Tianjin 12
Vienna 12
Campinas 11
Changsha 11
Da Nang 11
Hải Dương 11
Porto Alegre 11
Quito 11
Cairo 10
Dhaka 10
Frankfurt am Main 10
Guayaquil 10
Mexico City 10
Totale 13.686
Nome #
Biological Evaluation and Computational Modelling Studies on N-acyl Hydrazone and 2,5-Disubstituted 1,3,4-Oxadiazole Derivatives as Non-toxic Antimicrobial Agents 487
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors 382
Chemically stable inhibitors of 14-3-3 protein–protein interactions derived from BV02 302
Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains 283
(Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity 271
Structure, function, involvement in diseases and targeting of 14-3-3 proteins: An Update 267
Molecular insights to the bioactive form of BV02, a reference inhibitor of 14-3-3σ protein-protein interactions 266
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors 260
Differentially activated Src kinase in chemo-naive human primary osteosarcoma cells and effects of a Src kinase inhibitor 251
Discovery of in vitro antitubercular agents through in silico ligand-based approaches 251
In Memory of Maurizio Botta: His Contribution to the Development of Computer-Aided Drug Design 251
Potent and selective carboxylic acid inhibitors of tumor-associated carbonic anhydrases IX and XII 247
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein 244
Tautomers of a Fluorescent G Surrogate and Their Distinct Photophysics Provide Additional Information Channels 240
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3s case 234
Discovery of 14-3-3 Protein-Protein Interaction Inhibitors that Sensitize Multidrug-Resistant Cancer Cells to Doxorubicin and the Akt Inhibitor GSK690693 232
Identification of Phosphate-Containing Compounds as New Inhibitors of 14-3-3/c-Abl Protein-Protein Interaction 221
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro 218
Synthesis and Evaluation of Bifunctional Aminothiazoles as Antiretrovirals Targeting the HIV-1 Nucleocapsid Protein 212
A selective competitive inhibitor of aldehyde dehydrogenase 1A3 hinders cancer cell growth, invasiveness and stemness in vitro 208
Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor 205
Hit Recycling: Discovery of a Potent Carbonic Anhydrase Inhibitor by in Silico Target Fishing 204
Small molecules modulation of 14-3-3 protein–protein interactions 203
Inhibition of melanoma cell migration and invasion targeting the hypoxic tumor associated caxii 203
Identification of novel 2-benzoxazolinone derivatives with specific inhibitory activity against the HIV-1 nucleocapsid protein 198
Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors 196
Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1 194
A Class of Potent Inhibitors of the HIV-1 Nucleocapsid Protein Based on Aminopyrrolic Scaffolds 189
Mycobacterial carbonic anhydrase inhibition with phenolic acids and esters: kinetic and computational investigations 186
Structure Prediction and Validation of the ERK8 Kinase Domain 183
Naturally occurring Diels-Alder-type adducts from Morus nigra as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B 182
Multitarget hedgehog pathway inhibitors and uses thereof 181
Use of virtual screening for discovering antiretroviral compounds interacting with the HIV-1 nucleocapsid protein 171
Predicting the binding mode of known NCp7 inhibitors to facilitate the design of novel modulators 170
Free energy profile and kinetics studies of paclitaxel internalization from the outer to the inner wall of microtubules 168
1H-NMR metabolomics reveals the Glabrescione B exacerbation of glycolytic metabolism beside the cell growth inhibitory effect in glioma 168
Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines 167
Predicting the Binding Mode of Known NCp7 Inhibitors To Facilitate the Design of Novel Modulators 163
Targeting Protein-Protein and Protein-Nucleic Acid Interactions for Anti-HIV Therapy 161
A smo/gli multitarget hedgehog pathway inhibitor impairs tumor growth 157
Probing the Pore Drug Binding Site ofMicrotubules with Fluorescent Taxanes:Evidence of Two Binding Poses 154
Nucleocapsid protein: A desirable target for future therapies against HIV-1 153
Discovery of small molecule inhibitors of Leishmania braziliensis Hsp90 chaperone 152
Hedgehog Pathway Inhibition by Novel Small Molecules Impairs Melanoma Cell Migration and Invasion under Hypoxia 149
Molecular Dynamics and DFT Study on HIV-1 Nucleocapsid Protein-7 in Complex with Viral Genome 147
Discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (PtpB) inhibitors from natural products 146
Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge 145
Experimental and Computational Druggability Exploration of the 14-3-3ζ/SOS1pS1161PPI Interface 145
A Molecular Tool Targeting the Base-Flipping Activity of Human UHRF1 143
Nigritanine as a new potential antimicrobial alkaloid for the treatment of staphylococcus aureus-induced infections 143
Targeting GLI factors to inhibit the Hedgehog pathway 142
Natural products inspired modulators of cancer stem cells-specific signaling pathways notch and hedgehog 141
A novel colistin adjuvant identified by virtual screening for ArnT inhibitors 140
A Highly Soluble Matrix Metalloproteinase-9 Inhibitor for Potential Treatment of Dry Eye Syndrome 138
Oregonin from Alnus incana bark affects DNA methyltransferases expression and mitochondrial DNA copies in mouse embryonic fibroblasts 135
A chalcone derivative binds a putative allosteric site of YopH: Inhibition of a virulence factor of Yersinia 135
Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity 134
Alvaxanthone, a thymidylate synthase inhibitor with nematocidal and tumoricidal activities 131
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: synthesis and biological evaluation for chronic myeloid leukemia treatment 131
Statins interfere with the attachment of S. cerevisiae mtDNA to the inner mitochondrial membrane 130
Novel sulfamide-containing compounds as selective carbonic anhydrase i inhibitors 129
14-3-3 binding creates a memory of kinase action by stabilizing the modified state of phospholamban 129
Histone demethylating agents as potential S-adenosyl-l-methionine-competitors 126
Chalcones and Chalcone-mimetic Derivatives as Notch Inhibitors in a Model of T-cell Acute Lymphoblastic Leukemia 125
A deadly spillover: SARS-CoV-2 outbreak 124
P300/CBP-associated factor regulates transcription and function of isocitrate dehydrogenase 2 during muscle differentiation 122
Excited-State Dynamics of Thienoguanosine, an Isomorphic Highly Fluorescent Analogue of Guanosine 121
Discovery of a New Class of Potent MMP Inhibitors by Structure-Based Optimization of the Arylsulfonamide Scaffold 121
Current trends in Hedgehog signaling pathway inhibition by small molecules 120
Sofosbuvir selects for drug-resistant amino acid variants in the zika virus RNA-dependent RNA-polymerase complex in vitro 119
Synthetic thiosemicarbazones as a new class of Mycobacterium tuberculosis protein tyrosine phosphatase A inhibitors 116
INHIBITORS OF ANTIBIOTIC RESISTANCE MEDIATED BY ARN T 115
null 114
Synthesis of distal and proximal fleximer base analogues and evaluation in the nucleocapsid protein of HIV-1 113
What makes thienoguanosine an outstanding fluorescent DNA probe? 113
Selective targeting of cancer-related G-Quadruplex structures by the natural compound dicentrine 111
Yeast as a tool to select inhibitors of the cullin deneddylating enzyme Csn5 111
Conformational insights into the C-terminal mutations of human rhodopsin in retinitis pigmentosa 111
Inhibitors of UHRF1 base flipping activity showing cytotoxicity against cancer cells 110
Targeting the nucleocapsid protein of HIV-1 (NCp7) with nucleobase flexibility 110
Imidazo[1,2-a]pyridine derivatives as aldehyde dehydrogenase inhibitors: novel chemotypes to target glioblastoma stem cells 110
Inhibitory Effect of Lithospermic Acid on the HIV-1 Nucleocapsid Protein 110
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells 109
Hedgehog signaling pathway inhibitors: an updated patent review (2015–present) 108
Thienoguanosine, a unique non-perturbing reporter for investigating rotational dynamics of DNA duplexes and their complexes with proteins 107
Active Components from Cassia abbreviata Prevent HIV-1 Entry by Distinct Mechanisms of Action 107
Antimalarial drugs: what's new in the patents? 106
One hundred faces of cyclopamine 106
In Memory of Maurizio Botta: His Vision of Medicinal Chemistry 106
Natural products as an important source in drug discovery 105
Molecular Dynamics Simulations and Structural Analysis of Giardia Duodenalis 14-3-3 Protein-Protein Interactions 104
Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold 104
Identification of a novel chalcone derivative that inhibits Notch signaling in T-cell acute lymphoblastic leukemia 103
Dual SMO/BRAF inhibition by flavonolignans from Silybum marianum† 102
Natural flavonoid derivatives have pan-Coronavirus antiviral activity 101
null 100
Potency and Selectivity Optimization of Tryptophanol-Derived Oxazoloisoindolinones: Novel p53 Activators in Human Colorectal Cancer 98
Ent-Beyerane Diterpenes as a Key Platform for the Development of ArnT-Mediated Colistin Resistance Inhibitors 98
Synthesis of flexible purine analog inhibitors of NCp7 97
Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms 96
Totale 16.247
Categoria #
all - tutte 74.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.921


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.591 0 0 0 0 0 339 152 397 126 263 86 228
2021/20221.469 78 183 148 30 51 89 75 53 119 154 176 313
2022/20231.669 144 172 249 237 95 351 33 119 142 37 44 46
2023/20241.725 48 32 130 139 39 395 518 60 13 38 51 262
2024/20253.726 118 262 264 280 279 185 148 162 336 272 382 1.038
2025/20266.455 671 1.304 1.588 1.258 1.480 154 0 0 0 0 0 0
Totale 20.895